Login / Signup

How Do the Institute for Clinical and Economic Review's Assessments of Comparative Effectiveness Compare With the German Federal Joint Committee's Assessments of Added Benefit? A Qualitative Study.

Michael J DiStefanoSteven D PearsonDavid M RindAntal Zemplenyi
Published in: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research (2024)
The findings demonstrate that even under conditions where populations and comparators are identical and the evidence base is consistent, different assessors may arrive at divergent conclusions about comparative effectiveness, thus underscoring the presence of value judgments within assessments of clinical effectiveness. To support initiatives that seek to facilitate the exchange of value assessments between countries, these value judgments should always be transparently presented and justified in assessment summaries.
Keyphrases
  • randomized controlled trial
  • systematic review
  • quality improvement
  • genetic diversity